Evidence map›Paper›PMID 35768581›Full record

ArticleCommunications biology2022

Four-octyl itaconate improves osteoarthritis by enhancing autophagy in chondrocytes via PI3K/AKT/mTOR signalling pathway inhibition.

Xuekang Pan, Huajian Shan, Jinyu Bai, Tian Gao, Bao Chen, Zhonghai Shen, Haibin Zhou, Huigen Lu, Lei Sheng, Xiaozhong Zhou

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Itaconate and its derivatives in human health and diseases.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. [Mechanism Study of Aconitase 1 Promoting Hepatocellular Carcinoma Growth via the Itaconic Acid-Autophagy Axis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xuekang Pan *Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, 215004, Suzhou, China.
Huajian Shan *Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, 215004, Suzhou, China.
Jinyu Bai *Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, 215004, Suzhou, China.
Tian GaoDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, 314000, Jiaxing, China.
Bao ChenDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, 314000, Jiaxing, China.
Zhonghai ShenDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, 314000, Jiaxing, China.
Haibin ZhouDepartment of Orthopaedics, The Second Affiliated Hospital of Soochow University, 215004, Suzhou, China.
Huigen LuDepartment of Orthopaedics, The Second Affiliated Hospital of Jiaxing University, 314000, Jiaxing, China. 13758076161@163.com.ORCID http://orcid.org/0000-0002-4864-7239
Lei ShengDepartment of Orthopaedics, The Second Affiliated Hospital of Soochow University, 215004, Suzhou, China. shenglei510@suda.edu.cn.ORCID http://orcid.org/0000-0001-7729-9248
Xiaozhong ZhouDepartment of Orthopaedics, The Second Affiliated Hospital of Soochow University, 215004, Suzhou, China. zhouxz@suda.edu.cn.ORCID http://orcid.org/0000-0002-2202-7699
Soochow University · CNJiaxing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a highly prevalent and chronic disorder that is associated with a substantial social and economic burden. Itaconate, as an important regulator of cellular inflammation, is a metabolite synthesised by an enzyme encoded by immune-responsive gene 1. However, there are few studys regarding the effects of itaconate on OA. Here, we show the effect of the cell-permeable itaconate derivative 4-octyl itaconate (OI) on OA. OI attenuates the chondrocyte apoptosis induced by interleukin 1β (IL-1β) in vitro, indicating that OI protect chondrocytes against apoptosis. Moreover, OI ameliorates the chondrocyte autophagy inhibition induced by IL-1β via the inhibition of PI3K/AKT/mTOR signalling pathway. Finally, OI enhances autophagy and reduces cartilage degradation in a rat model of OA established by destabilization of medial meniscus (DMM). In summary, our findings reveal that OI is involved in regulating the progression of OA. The above results shed light on the treatment of OA.

Indexed as

ChondrocytesOsteoarthritisAnimalsAutophagyHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsSuccinatesTOR Serine-Threonine Kinasesitaconic acidMTOR protein, humanmTOR protein, ratPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSuccinatesTOR Serine-Threonine Kinases

Identifiers

PMID35768581
PMCPMC9242998
OpenAlexW4283742640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.